---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-136674"
form_type: "8-K"
ticker: "AKTX"
cik: "0001541157"
company_name: "Akari Therapeutics Plc"
filed_at: "2024-12-16T23:59:59+00:00"
generated_at: "2026-05-29T02:53:42.884978+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Akari Therapeutics appoints Torsten Hombeck as CFO effective Dec 16, 2024

## Summary
- Torsten Hombeck appointed CFO effective Dec 16, 2024; previously served as CFO from Oct 2019 to June 2024.
- Annual base salary of $300,000 with target bonus of up to 100%.
- Dr. Hombeck most recently served as CFO at Aspira Women's Health (June 2023–June 2024).
- No family relationships or transactions with other directors or officers noted.

## SEC filing metadata
- accession: 0000950170-24-136674
- form_type: 8-K
- ticker: AKTX
- cik: 0001541157
- company_name: Akari Therapeutics Plc
- filed_at: 2024-12-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1541157/000095017024136674/0000950170-24-136674-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1541157/000095017024136674/aktx-20241212.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-136674
- JSON: https://secwatch.observer/filing/0000950170-24-136674.json
- Plain text: https://secwatch.observer/filing/0000950170-24-136674.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.